The present scenario of cervical cancer control and HPV epidemiology in India: An outline

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1107-1115

  Giftson Senapathy, J ^a   Umadevi, P ^a   Kannika, P S ^b  

^a KARUNYA UNIVERSITY   (India)

^b DR N G P ARTS AND SCIENCE COLLEGE   (India)

Author keywords

Cervical cancer; Human papilloma virus; India; Risk factors; Screening; Vaccine

Indexed keywords

EID: 84857985216     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Aggarwal R, Gupta S, Nijhawan R, et al (2009). Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: A hospital based study from North India. Indian J of Cancer, 43, 110-116.
2. Alliance for Cervical Cancer Prevention (ACCP) (2004). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. Seattle: ACCP.
3. Arbyn M, Sasieni P, Meijer CJ, et al (2006). Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine, 24, 78-89.
4. Bang RA, Bang AT, Baitule M, et al (1989). High Prevalence of Gynaecological diseases in Rural Indian Women. Lancet, 1, 85-88.
5. Basu PS, Sankaranarayanan R, Mandal R, et al (2003). Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer, 13, 626-32.
6. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, et al (2001). Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 98, 441-44.
7. Bhatla N, Dar L, Patro AR, Kriplani A, Gulati A, et al (2006). Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol 25, 398-402.
8. Cancer Atlas India. Available at: http://www.canceratlasindia.org/chapter6.asp (last accessed: April 2008).
9. Cervical cancer: Fact sheet. National Institute of Health, September 2007.
10. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8.
11. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73.
12. Curado MP, Edwards B, Shin HR, et al (2007). Cancer Incidence in Five continents. IARC Scientic Publications No 160, Lyon: IARC Press, Lyon pp 90.
13. Dabash R, Vajpayee J, Jacob M, et al (2005). A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health 2, 11.
14. Denny L, Kuhn L, De Souza M, et al (2005). Screen and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 294, 2173-81.
15. Denny L, Kuhn L, Pollack A, Wainwright H, Wright T (2000). Evaluation of alternative methods of cervical cancer screening in resource poor settings. Cancer, 89, 823-26.
16. Denny L, Kuhn L, Pollack A, Wright TC Jr (2002). Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer, 94, 1699-707.
17. Dilip TR (2005). Extent of Inequity in Access to Health Care Services in India. In 'Review of Health Care in India', Eds Gangolli LV, Duggal R, Shukla A. Review of Health Care in India. Centre for Enquiry into Health and Allied Themes, pp. 247-268.
18. Directorate General of Health Services (1984). National Cancer Control Program of India. Government of India, New Delhi.
19. Duggal R, Gangolli LV (2005). Introduction to Review of Healthcare in India. In 'A Review of Healthcare in India', Eds Gangolli LV, Duggal R, Shukla. A Review of Healthcare in India. Centre for Enquiry into Health and Allied Themes, pp. 3-18.
20. Ferenczy A, France E (2002). Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncology, 3, 11-16.
21. Ferlay J, Bray F, Pisani P and Parkin DM (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1. 0. Lyon: IARC Press.
22. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press.
23. Franceschi S, Rajkumar R, Snijders PJ, et al (2005). Papillomavirus infection in rural women in southern India. Br J Cancer, 92, 601-6.
24. Franceschi S, Rajkumar T, Vaccarella S, et al (2003). Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer, 107, 127-33.
25. Gajalakshmi V, Rajaraman S, Shanta V (2000). A survival study of cancer in Chennai, India. Indian J. Cancer; 37, 158-164.
26. Gheit T, Vaccarella S, Schmitt M, et al. (2009). Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine 27, 636-639.
27. Goldie S, Galkin L, Goldhaber-Fiebert J, et al (2005). Cost effectiveness of cervical screening in ve developing countries. N Eng J Med, 353, 2158-2168.
28. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC (2001). Policy analysis of cervical cancer screening strategies in lowresource settings: clinical benets and cost-effectiveness. JAMA, 285, 3107-15.
29. IARC Handbooks on Cancer Prevention (2004). Cervix cancer screening. IARC Press, Lyon, 10.
30. IARC Working Group (1995). Human Papillomaviruses. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer, 65.
31. IARC working group: Summary (1986). In 'Screening for cancer of uterine cervix', Eds Hakama M. IARC scientific Publication No 76, Lyon, pp 133-42.
32. International Institute for Population Sciences (IIPS). National Family Health Survey (NFHS-3), India. 2005-2006. Ministry of Health and Family Welfare, Government of India. Available at: http://www.nfhsindia.org/pdf/IN.pdf (last accessed: April 2008).
33. Kim JJ, Ortendahl J, Goldie SJ (2009). Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States. Annals of Internal Medicine 151, 538-545.
34. Juneja A, Murthy NS, Tuteja RK, Sardana S, Das DK (1997). Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening. Neoplasma 44, 272-4.
35. Sarkar K, Bhattacharya S, Bhattacharyya S, Chatterjee S, Mallick AH, Chakraborti S, et al. (2008). Oncogenic human papilloma virus and cervical pre- cancerous lesions in brothel-based sex workers in India. Journal of Infection and Public Health 1, 121-128.
36. Krishnan Nair M, Sankaranarayanan R (1991). Epidemiological lead to cancer control. Cancer causes Control 2, 263-265.
37. Laara E, Day NE, Hakama M (1987). trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet I, 1247-1249
38. Laikangbam P, Sengupta S, Bhattacharya P, et al (2007). A comparative prole of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int J Gynecol Cancer 17,107-17.
39. Legood R, Gray AM, Mahe C, et al (2005). Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer, 117, 981-7.
40. Londhe M, George SS, Seshadri L (1997). Detection of CIN by naked eye visualization after application of acetic acid. Indian J Cancer 34, 88-91.
41. Mandal R, Mittal S, Basu P (2003). Management of cervical precancer. In 'Detection, diagnosis and management of cervical intraepithelial neoplasia'. Eds Lodha ND, Kamal MM. Nagpur, 1.
42. Mandelblatt JS, Lawrence WF, Galkin L, et al (2002). Costs and benets of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst, 94, 1469-83.
43. McInlay JB (1996). Some contributions from the social system to gender inequalities in heart disease. J Health Soc Behav, 37, 1-26.
44. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, et al (1998). The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol, 69, 205-9.
45. Murthy NS, Agarwal SS, Prabhakar AK, Sharma S, Das DK (1993). Estimation of reduction of life-time risk of cervical cancer through one life-time screening. Neoplasma, 40, 255-8.
46. National Sample Survey, 42nd and 52nd Round. National Sample Survey Organisation, Government of India. New Delhi.
47. Nene BM, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S, et al (2007). Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ, 85, 264-72.
48. Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM (2000). Lowcost technology for screening uterine cervical cancer. Bull World Health Organ, 78, 964-7.
49. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002). Cancer incidence in five continents. IARC Scientific Publication, 8, 155.
50. Paskett ED, Wewers ME, Rufn MT (2004). Educational Strategies for the Prevention of Cervical Cancer. In 'Cervical Cancer: From Etiology to Prevention', Eds Rohan TE, Shah KV. Kluwer Academic Publishers USA. 9, pp237-259.
51. Peedicayil A, Abraham P, Sathish N, John S, Shah K, Sridharan G, et al (2006). Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer, 16, 1591-5.
52. Priya R (2006). Towards 'Health Security' for Women and Children: Exploring Debates and Options. In 'Securing Health for All Dimensions and Challenges', Eds Prasad S, Sathyamala C. Institute for Human Development, New Delhi pp.328-352.
53. Priyanka Golikeri (2009). A new vaccine for cervical cancer and some good hope. Available at: http://cancersupport.aarogya. com/index.php?option=com_content&task=view&id=333&Itemid=361. Accessed November 2009
54. Qiao YL, Sellors JW, Eder PS, et al (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross sectional study of clinical accuracy in rural China. Lancet Oncol, 9, 929-36.
55. Rao DN, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-8.
56. Ratcliffe J (1983). Social justice and the demographic transition: lessons from India's Kerala State In 'Practicing Health for All', Eds Morley D, Rohde J and Williams G. Oxford University Press, pp 64-82.
57. Sangwa-Lugoma G, Mahmud S, Nasr SH, et al (2006). Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer, 119, 1389-95.
58. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al (2004). Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer, 110, 907-13.
59. Sankaranarayanan R, Budukh A and Rajkumar R (2001). Effective screening programs for cervical cancer in low- and middle-income developing countries. Bull World Health Organ, 79, 954-962.
60. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, et al (2004). Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer, 112, 341-7.
61. Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM (2000). Leads to cancer control based on cancer patterns in a rural population in south India. Cancer Causes Contr, 11, 433-9.
62. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al (2007). Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370, 398-406.
63. Sankaranarayanan R, Gafkin L, Jacob M, Sellors J, Robles S (2005). A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet, 89(2):4-12.
64. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, et al (2005). A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer, 116, 617-23.
65. Sankaranarayanan R, Rajkumar R, Arrossi S, Theresa R, Esmy PO, Mahe C, et al, (2003). Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev,27, 457-65.
66. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, et al (2007). Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer, 96, 738-43.
67. Sankaranarayanan R, Rajkumar R, Theresa R, et al (2004). Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer, 109, 461-67.
68. Sankaranarayanan R, Shastri SS, Basu P, Mahe C, Mandal R, Amin G, et al (2004). The role of low-level magnication in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev, 28, 345-51.
69. Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahe C, et al (2004). Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen, 11, 77-84.
70. Sankaranarayanan R, Wesley R, Thara S, et al (2003). Test characteristics of visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening. Int J Cancer, 106, 404-8.
71. Sankaranarayanan R, Wesley R. A Practical manual on visual screening for cervical neoplasia (2003). IARC Technical Publication No. 41, Lyon: IARC Press.
72. Schensul SL, Mekki-Berrada A, Nastasi BK, Singh R, Burleson JA, Bojko M (2006). Men's extramarital sex, marital relationships and sexual risk in urban poor communities in India. J Urban Health, 83, 614-24.
73. Sellors J, Sankaranarayanan R (2003). Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. Lyon: IARC Press.
74. Sen Amartya (2005). Introduction. In 'The Delivery of Primary Health Services. A Study in West Bengal and Jharkhand.' The Pratichi Health Report Number 1. TLM Books with Pratichi (India) Trust.
75. Shanta V, (2003). Perspectives in Cervical Cancer prevention in India. The International Network for Cancer Treatment and Research.
76. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al (2005). Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ, 83, 186-94.
77. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, et al (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116.
78. Stjernsward J, Eddy D, Luthra UK and Stanley K (1987). Plotting a new course for cervical cancer in developing countries. World Hlth Frm, 8, 42-45
79. University of Zimbabwe/JHPIEGO Cervical Cancer Project (1999): visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet, 353, 869-73.
80. Vallikad E, Krishnan S, Kumaraswamy (1998). Studies, Strategies and Concepts for Women's Health in Women's Hands: A Community Approach for the Control of Cancer Cervix in Karnataka, India. Kidwai Mem. Instit. Onco. Bangalore, India.
81. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah IV, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12-19.
82. Watkins K (1995). The Oxfam Poverty Report. Oxford, UK. The Pratichi Research Team. The Delivery of Primary Health Services. A Study in West Bengal and Jharkhand. The Pratichi Health Report. Number 1. 2005, TLM Books with Pratichi (India) Trust.
83. World Bank India (2001): Raising the Sights -Better Health Systems for India's Poor. Report No. 22304.
84. World Health Organisation (1986). Control of Cancer Cervix. Bull. WHO, 64,607-618.
85. World Health Organization Vaccine Preventable Diseases Monitoring System. Available at: http://www.who. int/vaccines/globalsummary/immunization/countryproleselect.cfm (last accessed: April 2008).
86. World Health Organization (2006). Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO.
87. World Health Organization. Reproductive health indicators database. Available at: http://www.who.int/reproductivehealth/globalmonitoring/RHRxmls/RHRmainpage.htm (last accessed: April 2008).